Neumora Therapeutics Says Navacaprant Did Not Achieve Primary Endpoint In KOASTAL-2 Or -3; Company To Discontinue Development Of Navacaprant

뉴스 본문을 불러오고 있어요.

Neumora Therapeutics Says Navacaprant Did Not Achieve Primary Endpoint In KOASTAL-2 Or -3; Company To Discontinue Development Of Navacaprant | 웨이프 WAPE

Neumora Therapeutics Says Navacaprant Did Not Achieve Primary Endpoint In KOASTAL-2 Or -3; Company To Discontinue Development Of Navacaprant

기사 요약

관련 종목

댓글 —